US 11253511
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)
granted A61KA61K2300/00A61K31/4745
Quick answer
US patent 11253511 (Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)) held by THE UNITED STATES OF AMERICA, as represented by th expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, as represented by th
- Grant date
- Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2300/00, A61K31/4745, A61K31/522, A61K38/05